Subscribe to Newsletter
Business & Profession Pediatric, Basic & Translational Research, Health Economics and Policy

Redressing Representation

Orginal image Adobe Stock

The under-representation of racial and ethnic minorities in clinical studies has been well-documented in existing literature; as recently as 2022, a report funded by the National Institutes of Health highlighted the continued lack of representation of these groups, existing “across numerous fields of medical research,” including cardiovascular, oncology, surgical trials, and ophthalmology (1).

The same issue affects pediatric ophthalmology, with a new JAMA Ophthalmology paper, “Race, Ethnicity, and Sex in Pediatric Eye Disease Investigator Group Clinical Studies,” revealing “a long-standing under-representation of Black, Asian, and Hispanic patients in PEDIG [Pediatric Eye Disease Investigator Group] studies,” says author Muhammad Z. Chauhan.

Chauhan and his team conducted a cross-section study of 41 completed PEDIG clinical trials involving 11,658 participants between 1997 to 2022. The researchers were primarily concerned with looking at how these trials reflected racial, ethnic, and gender representation in pediatric ophthalmology, and whether the trial participants accurately reflected the US pediatric population as reported in the 2010 US Census.

Using a 1-sample Wilcoxon rank test to compare results, the authors revealed that white participants were significantly over-represented in these clinical studies, whereas their Black, Hispanic, and Asian counterparts were underrepresented.

Specifically, the enrollment-census difference (ECD) – “defined as the difference between groups’ median enrollment percentage and percentage representation in the 2010 US Census” (2) – showed a 19 percentage over-representation of white participants, with Hispanic, Black, and Asian participants being underrepresented by 9 percent, 7 percent, and 3 percent respectively.

NEWS

The Ophthalmologist Presents:

The Ophthalmologist Weekly Newsletter

Enjoying yourself? There's plenty more where that came from! Our weekly newsletter from The Ophthalmologist brings you the most popular stories as they unfold, chosen by our fantastic Editorial team!

Register for our weekly newsletter

Given these results, the study recommends implementing changes in trial recruitment practices (e.g., “identifying and improving existing biases in recruiting” and incorporating enrollment limits based on disease prevalence).

Meanwhile, several interventions in PEDIG have already been implemented to better engage under-represented pediatric populations, notes co-author Abdelrahman M. Elhusseiny. “These include expanding access to enrollment materials in languages other than English, partnering with trusted healthcare providers who are well-established within communities and can advocate for PEDIG, and the creation of a dedicated committee to actively promote equity, diversity, and inclusion in study enrollment.” These initiatives have already begun to yield measurable improvements, notes Chauhan. “Notably, within just a short span of two years, we saw a marked increase in Hispanic patient enrollment, highlighting the positive impact of these efforts.”

The researchers believe there is still much work to be done within the space, however. “Advocating for expanded ophthalmology services in rural and socioeconomically underserved regions is essential,” adds co-author Qais A. Dihan. In addition, Dihan says that the socioeconomic barriers preventing families from participating in these clinical trials – such as transportation and flexibility of scheduling – also need to be addressed if we are to “resolve underlying issues that contribute to, and perpetuate, a cycle of inequitable care in underserved regions.”

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. K Bibbins-Domingo, A Helman (Editors), Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups, National Academies Press: 2022. PMID: 36137057.
  2. QA Dihan et al., “Race, Ethnicity, and Sex in Pediatric Eye Disease Investigator Group Clinical Studies,” JAMA Ophthalmology, [Online ahead of print] (2024). PMID: 39235786.
About the Author
Alun Evans
Related Case Study
Business & Profession Glaucoma
TrabEx Pro: The Next Level in MIGS

| Contributed by MST

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: